<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Nucleotide salvage defects" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Defects in APRT and HGPRT lead to synthesis of 2,8-dioxo-adenine and overproduction of uric acid, respectively, associated with kidney damage and other symptoms (BollÃ©e et al. 2012; Fu &amp; Jinnah 2012). Defects in ADA lead to accumulation of (deoxy)adenosine and consequent severe combined immunodeficiency (Akeson et al. 1988).
 View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9734207 Reactome].</Comment>
  <Comment Source="Reactome-Converter">Pathway is converted from Reactome ID: 9734207</Comment>
  <Comment Source="Reactome-version">Reactome version: 88</Comment>
  <Comment Source="Reactome Author">Reactome Author: D'Eustachio, Peter</Comment>
  <BiopaxRef>c1b</BiopaxRef>
  <BiopaxRef>da3</BiopaxRef>
  <BiopaxRef>d35</BiopaxRef>
  <Attribute Key="reactome_id" Value="9734207" />
  <Graphics BoardWidth="443.0" BoardHeight="397.0" />
  <DataNode TextLabel="Defective APRT&#xA;disrupts adenine&#xA;salvage" GraphId="a2406" Type="Pathway">
    <Comment Source="Reactome">Normally in humans, adenine formed in processes such as polyamine biosynthesis can be salvaged by conversion to AMP, catalyzed by APRT (adenine phosphoribosyltransferase). In the absence of APRT activity, however, accumulated adenine is instead converted to 2,8-dioxo-adenine. Accumulation of insoluble crystals of 2,8-dioxo-adenine in the kidneys causes the kidney damage that is a major symptom of APRT deficiency in humans (Van Acker et al. 1977; BollÃ©e et al. 2012).</Comment>
    <BiopaxRef>c1b</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="197.5" CenterY="77.0" Width="275.0" Height="68.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-9734195" />
  </DataNode>
  <DataNode TextLabel="Defective HPRT1&#xA;disrupts guanine&#xA;and hypoxanthine&#xA;salvage" GraphId="f278b" Type="Pathway">
    <Comment Source="Reactome">Normally in humans, guanine and hypoxanthine can be salvaged by conversion to GMP and IMP, catalyzed by HPRT1 (hypoxanthine guanine phosphoribosyltransferase). In the absence of HPRT1 activity, however, accumulated guanine and hypoxanthine are catabolized by XDH (xanthine dehydrogenase / oxidase) to urate (Fu &amp; Jinnah 2012).</Comment>
    <BiopaxRef>da3</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="202.5" CenterY="166.5" Width="271.0" Height="91.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-9734281" />
  </DataNode>
  <DataNode TextLabel="Defective ADA&#xA;disrupts&#xA;(deoxy)adenosine&#xA;deamination" GraphId="d1119" Type="Pathway">
    <Comment Source="Reactome">Normally in humans, adenosine and deoxyadenosine can be deaminated to inosine and deoxyinosine, catalyzed by ADA (adenosine deaminase). In the absence of ADA activity, however, accumulated nucleosides disrupt lymphoid cell function, leading to severe combined immunodeficiency (Hirschhorn et al. 1989, 1990).</Comment>
    <BiopaxRef>a3e</BiopaxRef>
    <BiopaxRef>d7f</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="202.0" CenterY="263.5" Width="274.0" Height="73.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-9734735" />
  </DataNode>
  <Label TextLabel="cytosol" GraphId="ccff3" GroupRef="ddebe">
    <Graphics CenterX="62.0" CenterY="328.5" Width="64.0" Height="33.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Shape GraphId="c5b61" GroupRef="ddebe">
    <Graphics CenterX="207.5" CenterY="184.5" Width="395.0" Height="349.0" ZOrder="16384" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="ddebe" GraphId="a34b5" Style="Group" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c1b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22700886</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adenine phosphoribosyltransferase deficiency.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bollée G, Harambat J, Bensman A, Knebelmann B, Daudon M, Ceballos-Picot I.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22157001</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genotype-phenotype correlations in Lesch-Nyhan disease: moving beyond the gene.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fu R, Jinnah HA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d35">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">3182793</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Akeson AL, Wiginton DA, Dusing MR, States JC, Hutton JJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a3e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2166947</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hot spot mutations in adenosine deaminase deficiency.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hirschhorn R, Tzall S, Ellenbogen A.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d7f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2783588</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hirschhorn R, Tzall S, Ellenbogen A, Orkin SH.</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>

